Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

95 trials

NCT07205523
Recruiting
High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)
Not applicable · China · 1 site
Registry update: 3 Oct 2025
NCT05022459
Recruiting
Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
Not applicable · United States · 10 sites
Registry update: 2 Jul 2026
NCT05981274
Recruiting
A Study on the Bone-health Effectiveness of Applying Recombinant Factor VIII Fc (rFVIIIFc) to Patients With Hemophilia A (Prototype A)
Not applicable · Taiwan · 1 site
Registry update: 10 Apr 2024
NCT06008938
Recruiting
An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B
Not applicable · Austria, Switzerland, Germany, Denmark, Spain, France, United States · 12 sites
Registry update: 19 Feb 2026
NCT05849740
Recruiting
An Exploratory Study of Cluster of Differentiation 38 (CD38) Monoclonal Antibody Combined Corticosteroid in Acquired Hemophilia A
Phase 4 · China · 1 site
Registry update: 5 Aug 2025
NCT06120582
Recruiting
Study of the Safety, Pharmacodynamics and Efficacy of ANB-002 in Patients With Hemophilia B (SAFRAN)
Phase 1/2 · Belarus, Russia · 17 sites
Registry update: 13 Jun 2025
NCT05802836
Recruiting
Dynamics of the Anti-factor VIII Antibody Signature During Treatment With Emicizumab
Not applicable · Germany · 1 site
Registry update: 10 Jul 2023
NCT05630651
Recruiting
The Efficacy and Safety of ZS801 in Chinese Hemophilia B Patients.
Not applicable · China · 1 site
Registry update: 24 Feb 2025
NCT05709288
Recruiting
Gene Therapy for Hemophilia B Patients Aged 12-18 Years Old
Phase 1 · China · 1 site
Registry update: 21 Feb 2025
NCT05629130
Recruiting
Embolization in Hereditary Coagulopathies
Not applicable · Brazil · 1 site
Registry update: 29 Nov 2022
NCT05568719
Recruiting
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
Phase 3 · Australia, Canada, Germany, Spain, France, Greece, Japan, South Korea, Saudi Arabia, Sweden, Taiwan, United States · 38 sites
Registry update: 7 Oct 2026
NCT05611801
Recruiting
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
Phase 3 · Argentina, Austria, Australia, Brazil, Canada, China, Czechia, Germany, Denmark, Spain, France, United Kingdom, Israel, India, Italy, Japan, South Korea, Mexico, Saudi Arabia, Slovakia, Taiwan, United States, South Africa · 63 sites
Registry update: 14 Oct 2026
NCT05500807
Recruiting
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Phase 1 · United States · 12 sites
Registry update: 3 Apr 2026
2022-502030-12-01
Recruiting
This is a first in human study, in patients with severe bleeding disorder (hemophilia A), who has developed inhibitory antibodies against coagulation factor VIII.The aim is to study the safety and efficacy of dendritic cells, originating from the patient itself. The dendritic cells has been loaded with coagulation factor VIII for an improved immunological tolerance. (TOLER8)
Phase 1 · Norway, Sweden · 2 sites
Registry update: 24 Mar 2025
NCT06320626
Recruiting
Pharmacokinetic-guided dosing of emicizumab in congenital haemophilia A patients – The DosEmi study
Phase 4 · Netherlands · 8 sites
Registry update: 11 Feb 2026
NCT04817462
Recruiting
Liver Biopsy In Haemophilia Gene Therapy
Not applicable · United Kingdom · 1 site
Registry update: 20 Dec 2024
NCT04676048
Recruiting
ASC618 Gene Therapy in Hemophilia A Patients
Phase 1/2 · United States · 1 site
Registry update: 1 Feb 2023
NCT04567511
Recruiting
Hemlibra in Mild Hemophilia A
Phase 4 · United States · 1 site
Registry update: 15 Mar 2024
NCT05454774
Recruiting
A Study of FVIII Gene Therapy for Hemophilia A
Early phase 1 · China · 1 site
Registry update: 21 Feb 2025
NCT05641610
Recruiting
A Study to Evaluate the Safety and Efficacy of ZS801 in Adult Hemophilia B Patients
Phase 1/2 · China · 1 site
Registry update: 24 Feb 2025

Ordered by registry start date. Freshness and sponsorship never change the order.